Editor’s Note Food & Drug Administration (FDA) commissioner, Scott Gottlieb, MD, on July 9 issued a statement on balancing access to appropriate treatment for patients with chronic and end-of-life pain with the need to stem the misuse and abuse of opioids. As the FDA considers new steps to address the opioid addiction crisis, Gottlieb says, […]
The post FDA statement on access to opioids for patients with chronic, end-of-life pain appeared first on OR Manager.